|
1
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: Pathology and prognosis at different sites. Semin
Diag Pathol. 23:70–83. 2006. View Article : Google Scholar
|
|
2
|
Miettinen M, Fletcher CD, Kindblom LG and
Tsui WM: Mesenchymal tumours of the oesophagus; mesenchymal tumours
of the stomach; mesenchymal tumours of the small intestine;
mesenchymal tumours of the colon and rectumWHO Classification of
Tumours of The Digestive System. Bosman FT, Carneiro F, Hruban RH
and Theise ND: 4th edition. International Agency for Research on
Cancer; Lyon: pp. 35–36, pp74-79, pp115-116, pp181-182. 2010
|
|
3
|
Rosai J: Rosai and Ackerman's surgical
pathology. 10th edition. Mosby/Elsevier; Philadelphia, PA: 2011,
View Article : Google Scholar
|
|
4
|
Rubin BP: GIST and EGISTEnzinger and
Weiss's soft tissue tumors. Goldblum JR, Folpe AL and Weiss SW: 6th
edition. Elsevier/Saunders; Philadelphia, PA: pp. 569–590. 2014
|
|
5
|
Miettinen MM, Corless CL, Debiec-Rychter
M, Fletcher JA, Lasota J, Rubin BP and Sciot R: Gastrointestinal
stromal tumorWHO Classification of Tumours of Soft Tissue and Bone.
Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: 4th edition.
International Agency for Research on Cancer; Lyon: pp. 164–167.
2013
|
|
6
|
Grant NG and Noffsinger AE: Mesenchymal
tumorsFenoglio-Preiser's Gastrointestinal Pathology. Noffsinger AE:
4th edition. Wolters Kluwer; Philadelphia, PA: pp. 1141–1222.
2017
|
|
7
|
Dematteo RP, Heinrich MC, El-Rifai WM and
Demetri G: Clinical management of gastrointestinal stromal tumors:
Before and after STI-571. Hum Pathol. 33:466–477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gouveia AM, Pimenta AP, Capelinha AF, de
la Cruz D, Silva P and Lopes JM: Surgical margin status and
prognosis of gastrointestinal stromal tumor. World J Surg.
32:2375–2382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Novitsky YW, Kercher KW, Sing RF and
Heniford BT: Long-term outcomes of laparoscopic resection of
gastric gastrointestinal stromal tumors. Ann Surg. 243:738–747.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Everett M and Gutman H: Surgical
management of gastrointestinal stromal tumors: Analysis of outcome
with respect to surgical margins and technique. J Surg Oncol.
98:588–593. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours. 8th edition.
Wiley-Blackwell; Hoboken: 2017
|
|
12
|
Joensuu H: Risk stratification of patients
diagnosed with gastrointestinal stromal tumor. Hum Pathol.
39:1411–1419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agaimy A and Wünsch PH: Sporadic Cajal
cell hyperplasia is common in resection specimens for distal
oesophageal carcinoma. A retrospective review of 77 consecutive
surgical resection specimens. Virchows Arch. 448:288–294. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Espinosa I, Lee CH, Kim MK, Rouse BT,
Subramanian S, Montgomery K, Varma S, Corless CL, Heinrich MC,
Smith KS, et al: A novel monoclonal antibody against DOG1 is a
sensitive and specific marker for gastrointestinal stromal tumors.
Am J Surg Pathol. 32:210–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miettinen M, Wang ZF and Lasota J: DOG1
antibody in the differential diagnosis of gastrointestinal stromal
tumors: A study of 1840 cases. Am J Surg Pathol. 33:1401–1408.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Langer C, Gunawan B, Schüler P, Huber W,
Füzesi L and Becker H: Prognostic factors influencing surgical
management and outcome of gastrointestinal stromal tumours. Br J
Surg. 90:332–339. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
DeMatteo RP, Lewis JJ, Leung D, Mudan SS,
Woodruff JM and Brennan MF: Two hundred gastrointestinal stromal
tumors. Recurrence patterns and prognostic factors for survival.
Ann Surg. 231:51–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhi X, Jiang B, Yu J, Røe OD, Qin J, Ni Q,
Sun L, Xu M, Zhu J and Ma L: Prognostic role of microscopically
positive margins for primary gastrointestinal stromal tumors: A
systematic review and meta-analysis. Sci Rep. 6:215412016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McCarter MD, Antonescu CR, Ballman KV,
Maki RG, Pisters PWT, Demetri GD, Blanke CD, von Mehren M, Brennan
MF, McCall L, et al: Microscopically positive margins for primary
gastrointestinal stromal tumors: Analysis of risk factors and tumor
recurrence. J Am Coll Surg. 215:53–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
